ArticleCancer science2022

TAS-116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T-cell leukemia.

Emi Ikebe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.